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Hematopoiesis is a tightly orchestrated process 
in which the hematopoietic stem cell (HSC) 
goes through symmetric and asymmetric divi-
sions to self-renew and also to differentiate into 
progenitors that can give rise to different cell 
lineages (Brümmendorf et al., 1999; Beckmann 
et al., 2007; Wu et al., 2007). The balance be-
tween self-renewal and differentiation of the 
HSCs needs to be regulated for supporting a 
normal hematopoietic system. However, not 
much is known about the programs that regulate 
this balance.
The Musashi (Msi) family of RNA-binding 
proteins, including Msi1 and Msi2, contribute 
to the control of symmetric and asymmetric 
stem cell division, regulate stem cell function, 
and play a role in cell fate determination (Okano 
et al., 2005). In Drosophila melanogaster, Musashi 
was first identified to be important for sensory 
neuron development, where it is essential for 
asymmetric division of neuroblasts into daugh-
ter cells with neuronal and nonneuronal poten-
tial (Nakamura et al., 1994). Loss of Musashi 
function results in defective asymmetric division 
and the formation of two nonneuronal daugh-
ter cells at the expense of commitment to the 
neuronal lineage (Nakamura et al., 1994). In ver-
tebrates, Msi1 and Msi2 are evolutionarily con-
served, harboring two tandem RNA recognition 
motifs and a carboxyl-terminal poly-A–binding 
protein association domain (Okano et al., 2005; 
Kawahara et al., 2008).
Msi proteins are thought to function by 
binding to the 3 untranslated regions (UTRs) 
of target mRNAs at a consensus sequence and 
then blocking translation by hindering access of 
the poly-A–binding protein to the elongation 
initiation complex (Kawahara et al., 2008). An 
inverse relationship between Msi and Numb 
expression as a result of Msi-mediated repression 
of Numb has been demonstrated in a variety of 
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Hematopoietic stem cells (HSCs) are maintained through the regulation of symmetric and 
asymmetric cell division. We report that conditional ablation of the RNA-binding protein 
Msi2 results in a failure of HSC maintenance and engraftment caused by a loss of quies-
cence and increased commitment divisions. Contrary to previous studies, we found that 
these phenotypes were independent of Numb. Global transcriptome profiling and RNA 
target analysis uncovered Msi2 interactions at multiple nodes within pathways that govern 
RNA translation, stem cell function, and TGF- signaling. Msi2-null HSCs are insensitive to 
TGF-–mediated expansion and have decreased signaling output, resulting in a loss of 
myeloid-restricted HSCs and myeloid reconstitution. Thus, Msi2 is an important regulator 
of the HSC translatome and balances HSC homeostasis and lineage bias.
© 2014 Park et al.  This article is distributed under the terms of an Attribution– 
Noncommercial–Share  Alike–No  Mirror  Sites  license  for  the  first  six  months 
after the publication date (see http://www.rupress.org/terms). After six months 
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high-throughput sequencing) profiling data allowed us to iden-
tify novel regulatory pathways downstream of Msi2 in HSCs 
(Chi et al., 2009).
RESULTS
Msi2 is required to maintain normal HSC numbers
To assess the role of Msi2 in the hematopoietic compartment, 
we developed a conditional knockout mouse model. We tar-
geted the Msi2 locus in embryonic stem cells with a construct 
containing loxP sites flanking the first four Msi2 exons (Fig. 1 a). 
After removal of the neomycin resistance selection cassette,   
a Msi2flox/flox mouse colony was established and crossed with 
Mx1-Cre mice to generate an inducible Msi2 loss of function 
strain (Msi2flox/flox::Mx1-Cre). To delete the Msi2 gene in cells 
of the hematopoietic lineage, we induced the Cre transgene 
in Msi2flox/flox::Mx1-Cre mice by three polyinosinic:polycyti-
dylic  acid  (pIpC)  injections,  which  efficiently  excised  the 
Msi2 gene from the BM and spleen, as assessed by Southern 
blot and quantitative real-time PCR (qRT-PCR) analysis 
within the hematopoietic stem and progenitor cells (HSPCs; 
LSK, Lineageloc-kit+, Sca+; Fig. 1, b and c). Msi2-deleted mice 
will be referred to as Msi2/ and control mice as either Msi2f/f 
or Msi2wt/ (heterozygous mice were phenotypically and func-
tionally the same as Msi2f/f).
systems, including myeloid leukemia cells (Imai et al., 2001; Ito 
et al., 2010; Kharas et al., 2010). Msi2 is an important modula-
tor of proliferation and differentiation in both normal HSCs 
and in myeloid malignancies (Hope et al., 2010; Ito et al., 2010; 
Kharas et al., 2010; de Andrés-Aguayo et al., 2011). Analysis of 
the hematopoietic compartment of Msi2 gene trap mice re-
vealed a reduced number of short-term HSCs and lymphoid 
primed myeloid progenitor (LMPP) cells, but no significant 
defect was found in long-term HSCs (de Andrés-Aguayo et al., 
2011). Although Msi2 is most highly expressed in the primitive 
hematopoietic compartment, and MSI2 overexpression drives 
quiescent HSCs out of G0 and into cycle (Kharas et al., 2010), 
it remains unclear whether and how Msi2 affects HSC self-
renewal and commitment under homeostatic conditions.   
Furthermore, the critical RNA-binding targets of Msi2 in 
hematopoietic cells that regulate self-renewal and lineage com-
mitment remain to be uncovered.
To determine the role of Msi2 in HSCs and avoid poten-
tially confounding compensatory mechanisms arising from 
germline Msi2 loss, we generated Msi2 conditional knock-
out mice that allowed us to study Msi2 function in a cell-
autonomous manner in adult tissues using spatiotemporally 
controlled deletion. Here, analysis of microarray data of   
Msi2 conditional knockout mice coupled with MSI2 HITS-
CLIP (cross-linking and immunoprecipitation followed by 
Figure 1.  Msi2 conditional knockout 
mice have reduced HSC numbers. (a) Tar-
geting scheme for Msi2 conditional knockout 
mice. (b) Southern blot of the indicated geno-
types 4 wk after pIpC treatment in vivo after 
XbaI digestion of genomic DNA and hybridiza-
tion with the probe depicted in panel a. (c) qRT-
PCR of Msi2 normalized to Gapdh from LSK 
(lineagelo, Sca+Kit+)-sorted cells from mice  
1 mo after pIpC injection (n = 3 per group). 
(d) Overall cell counts in mice as indicated 
after pIpC in the BM (left) and spleen (right; 
3–6 wk, n = 4; 18–22 wk, n = 9, 10 from two 
independent experiments). (e) Representative 
flow cytometric analysis from mice 3–6 wk 
after pIpC (mean and SEM; n = 12; three in-
dependent experiments). (f and g) Absolute 
number of LSK (f) and LSK+CD150+CD48 
cells (g) from the indicated mice after pIpC 
(3–6 wk: same mice as e; and18–22 wk: Msi2f/f, 
n = 12; Msi2/, n = 13 from four indepen-
dent experiments). Means and SEM are shown 
(*, P < 0.05; **, P < 0.01; ***, P < 0.001).JEM Vol. 211, No. 1 
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the frequency and absolute number of LSKs as early as 4 wk 
and reduced overall numbers of HSCs at 18 wk (Fig. 1, e–g; 
and Fig. S1).
Msi2/ HSCs are functionally defective in reconstitution
To test the function of Msi2/ HSCs, we transplanted the 
BM of Msi2/ or Msi2wt/ into congenic recipients. After 
a noncompetitive engraftment, we observed a reduction in 
spleen size and a dramatic reduction of donor chimerism at 
the level of phenotypic LSK+CD150+CD48 LSKs and he-
matopoietic progenitors after 6 mo (Fig. 2, a–c; and Fig. S2 a). 
To test whether Msi2 deletion was maintained in these long-
term HSC transplants, we performed qRT-PCR for Msi2 
in sorted CD45.2+LSK+ at various time points. Consistent 
Msi2/ mice had normal peripheral blood counts (not 
depicted) and BM and spleen cellularity at 3–6 wk after pIpC 
injections (Fig. 1 d). However, after 18 wk, the mice had   
reduced spleen weights (not depicted) and cellularity in the 
spleen and BM (Fig. 1 d). We previously observed alterations 
in myeloid differentiation upon MSI2 overexpression in vivo 
(Kharas et al., 2010). In contrast, we found no significant 
changes in the frequencies of mature myeloid cell types as 
well as B and T cells in the BM and spleen (not depicted). The 
decreased cellularity in both spleen and BM and phenotypes 
from a previous study on Msi2 suggested that there could be 
a defect in early stem and/or progenitor function (de Andrés-
Aguayo et al., 2011). Thus, we examined the overall frequency 
and numbers of HSCs in these mice and found a reduction in 
Figure 2.  Msi2 deficiency decreases repopulating activity. (a) 106 BM cells from mice treated with pIpC were transplanted, and these transplanted 
animals were sacrificed at 22–24 wk after pIpC with the indicated organ weights (n = 9 from two independent transplants). (b) Representative CD45.2  
chimerism flow plot for the HSCs, LSK CD48CD150+; mean and SEM shown next to gate and also in c. (c) CD45.2 chimerism analysis from HSCs, 
LSK+CD48CD150+. See Materials and methods for the surface phenotype of the progenitors (n = 8, 9, same experiment as in panel a). (d) qRT-PCR expression 
of Msi2 normalized to Gapdh in sorted LSKs from the indicated primary mice or transplanted mice (c) and analyzed at various time points after pIpC (primary 
mice 4 wk [before transplant] n = 4 per genotype; 12 wk [before transplant], n = 3 per genotype; and 16–24 wk [transplanted mice], n = 9 or n = 8 for Msi2f/f 
or Msi2/, respectively). (e) BM cells were sorted for HSCs, LSK CD34CD48CD150+, and 3,000 HSCs were transplanted into lethally irradiated mice together 
with 300,000 BM support cells. Peripheral blood was then examined at 10 wk after engraftment (n = 4 mice per genotype). (f) Congenic mice (CD45.1) were 
noncompetitively transplanted with control or Msi2flox/flox marrow and were allowed to engraft normally (6 wk); peripheral blood chimerism was analyzed 
before injection of pIpC. (g) Chimerism analysis 18 wk after pIpC from mice in f (see Fig. S2 a [control, n = 10; or Msi2/, n = 11 from three independent 
transplants] or Fig. S2 b for gating; LT-HSC: LSK+CD34FLK2/3, ST-HSC: LSK+CD34+FLK2/3, LMPP: LSK+CD34+FLK2/3+, representative of control, n = 3; or 
Msi2/, n = 5 mice). Means and SEM are shown (*, P < 0.05; **, P < 0.01; ***, P < 0.001). BMT, BM transplant.74 Musashi-2 balances HSC homeostasis | Park et al.
Consistent with a loss of stem cell homeostasis, we found 
that Msi2/ mice had a reduction in the G0 quiescent popu-
lation in both LSKs and HSCs (Fig. 3 a and Fig. S3 a). Quies-
cent cells within the HSC compartment have been shown   
to have higher engraftment potential in transplant assays 
(Passegué et al., 2005). To test whether the loss of Msi2 would 
sensitize the cells to proliferative stress, we challenged mice 
with 5-Fluorouracil (5-FU). These experiments were per-
formed in a cell-autonomous context in which unexcised 
BM was engrafted, injected with pIpC, and then analyzed at 
various time points after 6 wk. We noted a dramatic reduction 
of chimerism in the peripheral blood in the myeloid com-
partment and recovery within the monocytes in Msi2/ com-
pared with controls (Fig. 3 b). This reduction in chimerism was 
also observed in the phenotypic HSCs (LSK+CD150+CD48) 
in 5-FU–treated mice (Fig. 3 c and Fig. S3 b). Altogether, loss 
of Msi2 impairs HSCs during normal homeostasis, which is 
accentuated in response to perturbations including transplan-
tation and replicative stress.
Msi2 determines myeloid lineage bias
To determine whether lineage fate decisions were also altered, 
we reexamined all of our transplant experiments for differen-
tial chimerism between myeloid and lymphoid populations. 
with a role for Msi2 in maintaining the HSC compartment, we 
found that the residual chimerism in the LSKs (Fig. 2, b and c; 
and Fig. S2 a) represented cells that were unexcised for Msi2 
and maintained comparable Msi2 expression with the control 
(Fig. 2 d). To further test the requirement for HSC engraft-
ment, we repeated these experiments with sorted phenotypic 
HSC populations (LSK+CD150+CD48CD34) and support 
congenic BM (300k). We were unable to detect any chimerism 
of Msi2-deleted cells after 10 wk (Fig. 2 e). These data further 
suggest that Msi2 was required for the engraftment of HSCs.
To further delineate whether this phenotype is cell au-
tonomous, we noncompetitively transplanted cells from both 
control and Msi2flox/flox::Mx1-Cre BM, which were then en-
grafted normally into congenic recipients (Fig. 2 f). After 
engraftment, Msi2 deletion was induced by pIpC injection, 
and the peripheral blood was assessed 6 wk later. We ob-
served a reduction in the overall white blood cell count of 
mice engrafted with Msi2-deficient HSCs, including reduc-
tions in myeloid, lymphoid, and red blood cell numbers (not 
depicted). Similar to the transplants performed with Msi2/ 
BM cells, the chimerism of the residual host BM outcom-
peted the donor HSCs and progenitors (Fig. 2 g and Fig. S2 b). 
Collectively, these results indicate that Msi2 is critical for 
HSC engraftment.
Figure 3.  Msi2 deficiency reduces quiescence, and proliferative stress further depletes HSCs. (a) Representative flow cytometry cell cycle 
plots with statistical analysis (bottom; HSC: LSK CD34, HSPC: LSK CD34+; control, n = 10; Msi2/, n = 7 from three independent experiments). See 
Fig. S3 a for gating. (b) The indicated mice were transplanted noncompetitively, injected with pIpC, and after 6 wk were injected with 5-FU. Peripheral 
blood analysis was performed with measurements of monocytes at the indicated time points and were normalized back to the same animal before  
5-FU (n = 5, 8) and 6 wk after pIpC injections. (c) BM donor chimerism of HSCs (LSK CD48CD150+) of mice (n = 5, 8) was assessed at 9 wk after pIpC 
and from b 40 d after 5-FU and non–5-FU mice (control, n = 8; and Msi2/, n = 10 from three independent experiments). See Fig. S3 b for gating. 
Mean and SEM are shown (*, P < 0.05; **, P < 0.01; ***, P < 0.001). BMT, BM transplant.JEM Vol. 211, No. 1 
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cell level. Myeloid colony–forming assays with sorted pheno-
typic HSCs (LSK+CD150+CD48) or HSPCs (LSK+CD150 
and LSK+CD150+CD48+; Fig. S5) revealed decreased colony 
formation with significant reductions in multilineage myeloid 
differentiation (Fig. 5 a). Proliferation assays in the presence   
of myeloid cytokines on sorted HSCs and HSPCs resulted in 
reduced total cellular output (Fig. 5 b). Concurrently, we ob-
served an increase in the frequency of cells committed to dif-
ferentiation based on the expression of myeloid markers   
(Fig. 5 c). Collectively, Msi2 contributes to stem cell fate deci-
sions based on the reduced cellular output, decreased colony 
formation, and increased cellular commitment.
To determine whether the observed defect in Msi2/ 
HSCs could be caused by increased commitment divisions, 
we examined Numb protein levels and distribution in mitotic 
HSC daughter pairs. Numb can be used as a surrogate read-
out for asymmetric stem cell division and as a putative direct 
target of Msi2 mRNA binding in HSCs (Wu et al., 2007; 
Kharas et al., 2010). Surprisingly, we observed equivalent Numb 
Interestingly, we observed that the defect was more severe 
in the myeloid lineage compared with the lymphoid lineage 
(Fig. 4, a–c). This prompted us to further define the HSC 
compartment and assess the heterogeneous phenotypic cell   
types that can display lineage bias toward the myeloid or lym-
phoid fate (Uchida et al., 2003; Dykstra et al., 2007; Chambers 
et al., 2008; Beerman et al., 2010; Pang et al., 2011). We did 
not observe a reduction in common lymphoid progenitors 
(CLPs; Fig. 4 d and Fig. S4 a). Although there was no differ-
ence in the frequency of HSCs among the LSKs (Fig. S1), we 
found a three- to fourfold reduction in the frequency of 
myeloid-biased HSCs (My-HSCs; LSK+CD34CD48CD150hi 
or LSK+CD34CD48CD150hiCD86lo; Fig. 4, e and f; and 
Fig. S4 b; Shimazu et al., 2012).
Msi2/ HSCs have increased commitment  
toward differentiation
The reduced quiescence and increased sensitivity to stress 
prompted us to examine whether Msi2/ HSCs were defective 
in their ability to undergo lineage commitment at the single 
Figure 4.  Msi2/ cells have reduced myeloid lineage–biased HSCs and defective myeloid repopulating activity. (a) Chimerism analysis 
of the myeloid and lymphoid populations in the BM and spleen of mice 22–24 wk after transplant (same as in Fig. 2 [a and b]). (b) Chimerism of 
myeloid and lymphoid lineages in spleen of primary transplanted mice shown 12–18 wk after pIpC (n = 9, 10 from two independent experiments). 
(c) Chimerism analysis 9 wk after pIpC and 40 d after 5-FU injections (same as in Fig. 3 [b and c]). (d) Chimerism analysis at 18 wk after pIpC, and 
CLP (Linloc-kitmidSca+Flk2+IL7R+, CLP2: Linloc-kitloSca+Flk2+IL7R+) populations are based on gating in Fig. S4 a (control, n = 3; or Msi2/, n = 5 mice). 
(e) Representative flow analysis (left; with indicated staining from 18-wk-post-pIpC mice). Mean and SEM for the frequency of CD150hi My-HSCs 
gated from (left flow plot) 4 wk (n = 12 and n = 15 from five independent experiments) and 18 wk (n = 5 and Msi2/ n = 8 from two independent 
experiments). (f) Flow cytometric analysis of My-HSCs: LinloCD45.2+LSK CD150hiCD86 (n = 6, n = 8 mice from two independent experiments). See gating 
strategy in Fig. S4 b. SEM is shown (*, P < 0.05; **, P < 0.01; ***, P < 0.001). BMT, BM transplant.76 Musashi-2 balances HSC homeostasis | Park et al.
segregation in the HSPCs and an increase in the percentage 
of cells with symmetric commitment Numb staining in both 
the HSCs and HSPCs (Fig. 5 e). These results suggested that 
loss of Msi2 skewed stem cell fate decisions in favor of com-
mitment divisions.
protein levels in Msi2/ HSCs or HSPCs compared with the 
control cells. This result indicates that Msi2 deficiency does 
not alter the global protein levels of Numb within an indi-
vidual cell (Fig. 5 d). However, we did observe a decrease in 
the percentage of cells that underwent asymmetric Numb 
Figure 5.  HSCs and HSPCs from Msi2-deficient mice have reduced self-renewal divisions with differentiation independent of the  
Numb. (a) The indicated sorted populations were plated in myeloid methylcellulose colony assays (left, HSC: LSK+CD150+CD48; and right, HSPC: 
LSK+CD150+CD48+ and LSK CD150; means and SEM from n = 6 control and n = 5 Msi2/ from two independent experiments; *, P < 0.05 for CFU-
GM, CFU-G, and CFU-GEMM). G, granulocyte, GM, mixed granulocyte and monocyte colony; BFU-E, burst-forming units erythroid lineage; GEMM, 
mixed granulocyte, erythroid monocyte, and megakaryocyte; MEG, megakaryocyte. (b) Indicated sorted populations from Msi2/ donors (6–9 wk; HSC 
mice: n = 14–15 per genotype from six independent experiments; HSPC mice: n = 5 from two independent experiments) were grown for 5 d, and cell 
numbers were divided by the number of cells in the control wells (see Fig. S5 for gating). (c) Representative flow for mature myeloid markers from 
HSCs grown same as in b and percentage of Mac-1–positive cells (histogram; control, n = 15; and Msi2/, n = 13 HSCs). (d) Sorted control and 
Msi2/ HSCs and HSPCs from mice 4 wk after pIpC treatment cultured in vitro for 36 h and stained for expression of Numb and DAPI (four to five 
mice from two independent experiments; HSCs, n = 42 and 46 cells; HSPCs, n = 76 and 94). (e) Representative images for paired Numb daughter  
assay with DAPI (middle) and brightfield images (left) and experimental scheme (right) for studying asymmetric division in HSCs/HSPCs. Percentage of 
doublet cells in each type of cell division is shown (n = 4–5 individual mice from two independent experiments; total HSCs daughter pairs: 22 and 72, 
HSPC pairs: 84 and 107). Bars, 10 µm. Mean and SEM are shown (*, P < 0.05; **, P < 0.01; ***, P < 0.001).JEM Vol. 211, No. 1 
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Figure 6.  Loss of self-renewal gene expression program and increased differentiation in Msi2-deficient HSPCs. (a and b) Microarray heat maps of 
differentially expressed genes with the top 40 down-regulated (a) and top 40 up-regulated genes (b) shown and also ranked based on Student’s t test values 
(n = 4 per genotype; 4 wk after pIpC) of sorted LSKs. (c) Self-renewal and differentiation gene sets analyzed from the transcriptome analysis comparing con-
trol and Msi2/ LSKs (same as in a and b). Enrichment score (ES) is shown. (d) qRT-PCR analysis of the indicated hematopoietic self-renewal and lineage 
transcription factors in sorted LSK+CD150+CD48CD34 cells from Msi2/ and Msi2f/f (n = 3 per genotype). (e) Sorted LSK+CD150+CD48 cells were stained 
with c-MYC–specific Ab (left) and DAPI (middle); a merged image is shown (right). Bars, 10 µm. Fluorescent intensity was quantified and normalized to the 
control (three independent experiments; 171 and 248 cells quantified per group in total). Means and SEM are shown (*, P < 0.05; ****, P = 3.56 × 107).78 Musashi-2 balances HSC homeostasis | Park et al.
Figure 7.  MSI2’s direct RNA targets are involved in RNA metabolism and the self-renewal signaling program. (a) Schematic outline of the 
HITS-CLIP approach. (b) Target genes are mouse genes homologous to human MSI2 targets identified by HITS-CLIP in K562 (FDR < 0.1) and background 
genes are all the other genes expressed in mouse LSK cells. Log2 fold changes (logFCs) of gene expression between knockout and wild-type samples are 
fitted using limma package. When there are multiple microarray probes mapped to the same gene, logFC of that gene is represented by the median of all 
corresponding probes. P-value is obtained with one-sided K-S test on the logFC distributions of target and background genes (green line indicates the 
intersection of the HITS-CLIP targets with a zero logFC). CDF, cumulative distribution function. (c) Up- and down-regulated genes that are differentially JEM Vol. 211, No. 1 
Article
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MSI2’s direct RNA binding targets control translation  
and the self-renewal program in HSCs
We decided to take a global approach to understanding how 
Msi2 loss alters the cellular program of stem cells. We first ex-
amined the pathways that were altered in the Msi2/ LSK by 
performing transcriptome profiling at 4 wk after Msi2 dele-
tion. We found 311 differentially expressed genes, of which 
208 were down-regulated and 103 were up-regulated (fold 
change > 1.5; feature P < 0.05; Table S1). To easily visualize 
the top differentially expressed genes, we generated a heat 
map of the top 40 down-regulated and up-regulated genes 
(ranked by t-statistic; Fig. 6, a and b). We then functionally 
annotated our expression profiling and performed Gene Set 
Enrichment Analysis (GSEA; Subramanian et al., 2005) on   
all curated gene sets in the Molecular Signatures Database 
(MSigDB; 4,850 gene sets) combined with an additional set 
of relevant gene sets (90 gene sets from our experimentally 
derived or published hematopoietic self-renewal and differ-
entiation signatures [Subramanian et al., 2005]; see Table S2). 
We found 13 gene sets (false discovery rate [FDR] < 0.01 and 
>20 genes) that were enriched in the control LSKs and 92 
gene sets enriched in the Msi2/ LSKs (Table S3). We found 
that the Msi2/ LSKs have down-regulated genes that are 
normally expressed in the self-renewal signature of HSCs. 
Also, the Msi2/ LSKs have up-regulated genes associated 
with differentiation to megakaryocyte erythroid progenitor 
(MEPs), common myeloid progenitors (CMPs), and granulo-
cyte monocyte progenitors (GMPs; Fig. 6 c and Table S3). 
These data suggest that Msi2 maintains the stem cell gene ex-
pression program. We decided to examine the expression of a 
set of lineage transcription factors in a more phenotypically 
purified HSC population (LSK+CD150+CD48CD34). We 
found reductions in Egr1, Gfi1, and Junb expression with a 
modest, but significant increase in c-Myc transcript (Fig. 6 d). 
Consistent with the increase in the mRNA level, we also 
found increased c-MYC protein within the phenotypic HSCs 
(LSK+CD150+CD48; Fig. 6 e). These data further supported 
the role for Msi2 in maintaining the self-renewal program and 
an increase in the commitment in the HSCs.
Although we observed significant alterations in multiple 
pathways in LSKs, it remained unclear whether this was a re-
sult of a direct mechanism of action. Therefore, we decided   
to globally assess direct MSI2-binding targets by UV cross-
linking and immunoprecipitation of MSI2, followed by RNase 
digestion of unbound RNA and RNA sequencing of the   
resulting protected fragments (HITS-CLIP; Fig. 7 a). Because 
of  the  technical  challenge  of  the  HITS-CLIP  protocol, 
which requires large amounts of starting material (i.e., 100 
million cells) to capture specific interactions between endog-
enous proteins and target RNA, we overexpressed a FLAG-
tagged version of MSI2 in parallel to a control vector lacking 
the MSI2 cDNA in K562 leukemia cells (Fig. 7 a). After per-
forming HITS-CLIP, sequencing read alignment, and peak 
calling using our previously published algorithm (Loeb et al., 
2012), we tested CLIP peaks for significant differential MSI2 
binding over control and normalized peak expression by dif-
ferential expression of all genes by RNA sequencing, using a 
joint statistical model of HITS-CLIP and RNA sequencing 
read count data. We found 1,097 unique targets that have at 
least one significant MSI2-binding site (FDR < 0.1 with a cor-
rected CLIP log fold change of two or more). We observed 
binding  that  was  distributed  between  the  coding  DNA   
sequence (CDS) and the UTRs (56% and 44%, respectively; 
Table S4). To determine whether gene expression changes   
in the LSK microarray after Msi2 deletion were enriched   
for direct Msi2 mRNA–binding HITS-CLIP targets, we per-
formed a cumulative distribution function and found a statisti-
cally significant difference in HITS-CLIP targets compared 
with the background gene expression (genes expressed in 
LSKs but are not HITS-CLIP targets) that was expressed in 
the LSKs (right shift; p-value = 6.92 × 1016; Fig. 7 b). Fur-
thermore, 70% of the HITS-CLIP target genes were in-
creased in expression after Msi2 deletion in the LSKs, and of 
these, 30% demonstrated a reduction of expression in the 
Msi2/ LSKs compared with the control (Fig. 7 b). More-
over, we identified seven up-regulated genes and six down-
regulated genes that were both differentially expressed in the 
LSKs and were HITS-CLIP targets (Fig. 7 c). These genes 
represented a wide variety of pathways, including RNA regu-
lators, cell cycle, and various metabolic pathways. We then re-
examined a subset of these genes in K562 cells by qRT-PCR. 
To validate our approach, we performed an additional RNA 
immunoprecipitation (RIP) experiment with antibodies (Abs) 
that target either endogenous MSI2 or the flag-tagged ver-
sion of MSI2 (Flag-MSI2; Fig. 7 d). We were able to detect 
enrichment in the RIP experiments using the MSI2-targeting 
Abs compared with control cells that expressed the pBabe 
empty vector or control Ab (anti–rabbit IgG) in six out of the 
seven targets that were retested, suggesting that our HITS-CLIP 
and mRNA overlap was reproducible (Fig. 7 d).
We then again queried the MSigDB signatures with GSEA 
(Subramanian et al., 2005) using the full list of ranked (by fold 
change) RNA CLIP targets to understand the functional clas-
sification of MSI2’s direct RNA targets. MSI2 binding was 
expressed and overlap with the top HITS-CLIP targets. (d) Validation using qRT-PCR of a subset of the HITS-CLIP targets from c with RIP performed with 
anti-FLAG Ab and Ab specific for MSI2 in K562 cells (mean of two independent RIP experiments and fold change over control samples; pBabe cells were 
used as control for Flag Ab sample, and anti–rabbit Ab was used as control for Msi2 Ab). SEM is shown. (e) Venn diagram indicating the number of sta-
tistically significant gene sets from the HITS-CLIP or the transcriptome analysis comparing controls and Msi2/ LSKs (FDR < 0.01). The number in the 
middle indicates the overlapping significant gene sets that are enriched in both the HITS-CLIP and the transcriptome analysis of LSKs. (f and g) Modules 
indicate the relationships between manually curated and selected gene sets (within the overlap in e and Table S6). “% overlap” indicates the number of 
genes that are common between the genes set.
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Figure 8.  Msi2 regulates TGF- signaling. (a) mRNA expression of Tgfbr1 in LSK+CD150+CD48CD34 (n = 3 per genotype). (b) Sorted 
LSK+CD150+CD48 cells from the indicated mice were stained with a TGFBR1-specific Ab (left) and DAPI (middle); a merged image is shown (right). Fluor-
escence was quantified and normalized to the control; the result is from three independent experiments; 292 and 175 cells were quantified per group in 
total. (c) Sorted LSK+CD150+CD48 cells were stained with pSmad2/3-specific Ab (representative image from freshly isolated cells, left) and DAPI (middle); JEM Vol. 211, No. 1 
Article
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Altogether, these modules indicate a complex role for MSI2 in 
regulating multiple critical cellular processes and pathways.
MSI2 modulates the TGF- signaling pathway
Although the role for Msi2 in HSCs is multidimensional and 
complex, we decided to focus on the interaction between 
MSI2 and the TGF- pathway for multiple reasons. Previous 
studies have demonstrated that TGF- signaling is critical for 
HSC quiescence, cell cycle, and differentiation (Sitnicka et al., 
1996; Kale and Vaidya, 2004; Kale, 2004; Yamazaki et al., 2011), 
and Msi2/ LSKs had significantly down-regulated Tgfbr1  
(Fig. 6 a). Moreover, the novel relationship between MSI2 and 
the  TGF- pathway is of interest as it came up in our HITS-CLIP 
and microarray data. Therefore, our combined genomic ex-
periments coupled with our functional experiments prompted 
us to further examine the link between MSI2 and TGF- 
signaling. First, we wanted to test whether Tgfbr1 expression 
levels were also down-regulated when we examined more 
phenotypically pure HSCs (LSK+CD150+CD48CD34). 
Consistent with our microarray results within the LSKs, we 
observed a reduction at the level of the mRNA expression in 
Msi2/ HSCs (Fig. 8 a). However, when we further tested 
whether this resulted in the reduction in protein expression, 
we observed the opposite result with a significant increase in 
TGFBR1 in sorted LSK+CD150+CD48 cells (Fig. 8 b). This 
prompted us to further test the output of the TGF- pathway 
in LSK+CD150+CD48 cells in the presence and absence of 
Msi2. An established readout for TGF- signaling is the phos-
phorylation of downstream effectors, including Smad2/3. In 
contrast to the increase in receptor expression, we found re-
duced phosphorylation of Smad2/Smad3 in Msi2/ HSCs 
(LSK+CD150+CD48) directly isolated from BM or grown 
in vitro (Fig. 8, c and d). Another readout for TGF- signaling 
in HSCs is the expression of one of its direct target genes, p57 
(Scandura et al., 2004; Brenet et al., 2013). Recently, it has 
been reported that the loss of p57 in HSCs results in reduced 
quiescence and compensatory up-regulation of p27 (Cheng 
et al., 2001; Matsumoto et al., 2011; Zou et al., 2011). Con-
sistent with reduced signaling output of TGF-, we observed 
a significant decrease in p57 expression and up-regulation of 
p27 in Msi2/ LSKs (Fig. 8 e).
These results further suggest a defect in the output of the 
TGF- signaling pathway in vivo. The effect of TGF- treat-
ment is biphasic in HSCs, with high levels of TGF- blocking   
positively enriched for 668 gene sets (FDR < 0.01; Table S5), 
whereas the nonspecific RNA interactions (low or negative 
fold change) failed to identify any significant pathways. These 
data suggest that MSI2 RNA binding generates a defined cel-
lular program that may not be simply attributed to alterations 
of individual targets in a pathway. Similar to examining the in-
dividual genes in LSKs (Fig. 7 b), this large number of gene sets 
prompted us to further filter and overlap the molecular signa-
tures with our data from the LSK microarray. Thus, we identi-
fied 52% (48 out of 92) gene sets enriched as MSI2-binding 
targets that were also enriched in the transcriptome data analy-
sis from Msi2/ LSKs (Fig. 7 e), providing a union between 
MSI2 RNA binding activity and subsequent transcriptional 
regulation of these pathways (Table S6). Interestingly, the gene 
sets were unidirectional, demonstrating enrichment only in the 
Msi2/ LSKs and not in the control cells, implying that the 
majority of Msi2’s targets are being repressed. Of the 48 gene 
sets, we narrowed down the gene sets that were associated with 
hematopoietic biology. We then examined the genes sets and 
categorized them into two defined modules: “RNA regulation 
and electron transport” and “Signaling and development” gene 
sets (Fig. 7, f and g; and Table S6). We displayed the size of the 
gene sets (circle diameter) and the overlap of the individual 
genes between the identified gene sets (connecting line thick-
ness) to visualize the relationship of these functional pathways. 
For example, within RNA regulation and electron transport, 
genes sets associated with genes that are normally down- 
regulated after mTOR inhibition (i.e., rapamycin, leucine, or 
glutamine deprivation) were both enriched for MSI2 binding 
and up-regulated in Msi2/ LSKs. This central node connected 
three distinct peripheral nodes that included energy metabo-
lism, mRNA processing, and translation (Fig. 7 f ). In the   
signaling and development module, a variety of pathways in-
cluding a developmental program of “HSC versus CMP” and 
“Self-renewal” and other signaling pathways including, Hy-
poxia, RAS, MYC, and CYCLIND1, among others, were de-
tected, and the overlap among the genes within the cluster   
was 8% or less (Fig. 7 g). Interestingly, the Self-renewal and 
HSC versus CMP gene sets (already discussed in Fig. 6) further 
overlapped with HITS-CLIP targets. We also observed four 
Myc-related gene sets that overlapped with HITS-CLIP tar-
gets, which also contained 8% or fewer of the individual genes 
overlapping. Additionally, we observed that the TGFB1 path-
way also overlapped with our HITS-CLIP targets (Fig. 7 g). 
a merged image is shown (right). Immunofluorescence was quantified and normalized to the control; results are from two independent experiments; 465 
and 540 cells were quantified per group in total. (d) LSK+CD150+CD48 cells were grown in culture for 2 d. 38–40 cells were quantified per group in total 
from three independent experiments. (e) qRT-PCR of cell cycle regulators and p57 target gene of TGF- signaling from control and Msi2/ LSKs (n = 5, 
two independent experiments). (f) LSK+CD150+CD48 sorted populations from control and Msi2/ donors (6–9 wk; HSC mice: n = 3–8 mice from the 
control for each condition and 3–10 for the Msi2/ from up to six independent experiments) were grown (50 cells per well were plated initially for 7 d), 
and absolute cell numbers are shown. (g) qRT-PCR of Smad3 from LSK+CD150+CD48CD34 cells (n = 3 per genotype). (h) BM cells were sorted for 
LSK+CD150+CD48 and stained with a specific Ab for SMAD3 (fluorescence was quantified and normalized to the control; four independent experiments; 
531 control and 379 Msi2/ cells quantified per group in total). (b, c, and h) Bars, 10 µm. (i) qRT-PCR of TGFBR1 and SMAD3 HITS-CLIP targets with RIP 
performed as in Fig. 7 d with FLAG and a rabbit Ab specific for MSI2 in K562 cells (mean of two independent RIP experiments and fold change over con-
trol samples and SEM). Means and SEM are shown (*, P < 0.05; **, P < 0.01; ****, P = 1.17 × 1041).
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normal hematopoiesis (Fig. 9). Applying global RNA target 
analysis of MSI2 binding in leukemic cells combined with 
transcriptional analysis in mouse HSCs, we identified com-
mon self-renewal and differentiation pathways. Additionally, 
our approach uncovered a novel role for Msi2 in the regula-
tion of TGF- signaling by demonstrating reduced TGF- 
signaling output and impaired response to TGF- stimulation 
in Msi2-deficient HSCs.
Previous studies from our group and others have identi-
fied a role for Msi2 in hematopoietic development, but it re-
mained unclear how Msi2 functions and what pathways Msi2 
regulates in hematopoietic cells (Hope et al., 2010; Ito et al., 
2010; Kharas et al., 2010; de Andrés-Aguayo et al., 2011). Our 
study is consistent with experiments using shRNAs specific 
to Msi2 that revealed a block in the engraftment of Msi2- 
depleted cells (Hope et al., 2010; Kharas et al., 2010). How-
ever, our study differs with the analysis of hematopoietic cells 
from mice harboring an insertional gene trap at the Msi2 locus. 
Although these mice demonstrated a general reduction in re-
populating activity in vivo, they attribute this defect to the 
LMPP and not the HSC (de Andrés-Aguayo et al., 2011). We 
find reductions in LSKs and LMPPs, but also find a significant 
defect in the HSCs after genetic ablation of Msi2. Consistent 
with the gene trap loss of function Msi2 mice, we also ob-
served a reduction of circulating myeloid cells (de Andrés-
Aguayo et al., 2011). We found that this defect initially 
occurred at the level of the My-HSC. Similarly, the same 
study suggested that there was a proliferative defect in the 
LMPP compartment. We were unable to detect reduced cycling 
cells, but found a failure to maintain quiescence and skewing 
away from symmetric self-renewal divisions toward differen-
tiation in phenotypic HSCs. Transcriptome analysis in the 
gene trap mice suggested a loss of Myc target gene expression, 
whereas we observed the opposite: an increase of Myc target 
gene expression and increased levels of Myc in the HSC com-
partment at the mRNA and protein level. The apparent dis-
crepancy in the defect within the HSCs between the two 
mouse models suggests that the loss of Msi2 may be compen-
sated during development or could be caused by differences 
between gene trap–mediated insertional disruption and the 
conditional deletion approach in vivo.
Experiments on the Msi family have considered Numb   
to be a critical downstream target of Msi mRNA binding   
and translational suppression (Imai et al., 2001). In contrast to 
proliferation and low levels of this pathway activation leading 
to increased proliferation (Kale and Vaidya, 2004; Kale, 2004). 
We therefore examined the functional response of Msi2/ 
HSCs to various levels of TGF- signaling in vitro. The   
reduced TGF- signaling observed in steady-state Msi2/ 
HSCs was overcome by the addition of high doses of exoge-
nous TGF-, resulting in potent growth suppression regardless 
of Msi2 status (Fig. 8 f). In contrast, when exposed to a dose 
(0.01  ng/ml)  of TGF-  shown  to  expand  normal  HSCs, 
Msi2/ HSCs failed to respond, consistent with dimin-
ished sensitivity to the proliferative effects of TGF-1 (Fig. 8 f). 
However, this effect was lost at the lower doses of TGF-, 
suggesting a narrow window for this effect. Interestingly, a   
recent study has also identified an increase in proliferation 
within  the  My-HSC  compartment  after  stimulation  with 
0.01 ng/ml TGF-1 (Challen et al., 2010). Furthermore, our 
results that indicate reduced output in signaling and prolifera-
tion match the marked reduction we observed specifically 
within the My-HSCs (Fig. 4, e and f).
To further understand how Msi2 loss could negatively con-
trol TGF- output, we tested the mRNA expression of Smad3 
and found equivalent levels in the LSK+CD150+CD48CD34 
(Fig. 8 g). In contrast to the TGFBR1 regulation and consistent 
with the phosphorylation of SMAD2/3, we found a reduction 
in the total SMAD3 abundance in the LSK+CD150+CD48 
(Fig. 8 h). Although TGFBR1 and SMAD3 were not in the 
list of the top HITS-CLIP targets (FDR < 0.1), we did de-
tect direct Msi2 binding in our HITS-CLIP (TGFBR1: fold 
change of 12.78 compared with control, p-value = 0.02, FDR 
= 0.12; and Smad3: fold change of 3.2, p-value = 0.02, FDR 
= 0.11; Table S6). We then validated this binding with an ad-
ditional RIP for TGFBR1 and SMAD3 (Fig. 8 i). Altogether, 
these data suggested that Msi2 was directly modulating the 
TGF- pathway at multiple nodes.
DISCUSSION
In this study, we examined the role of Msi2 in HSCs using   
a conditional knockout mouse model. Conditional ablation 
of Msi2 in the hematopoietic system results in dramatic re-
ductions in steady-state HSC and HSPC numbers, with no 
changes in maturation of myeloid or lymphoid hematopoi-
etic lineages in primary mice. We demonstrate that Msi2 is 
required for HSC quiescence and maintaining the balance of 
self-renewal and symmetric commitment that is required for 
Figure 9.  Model of Msi2 function in 
HSCs. (left) Myeloid- and lymphoid-biased 
HSCs undergo balanced symmetric and asym-
metric divisions, giving rise to differentiated 
progeny. Normal My-HSCs proliferate in re-
sponse to low levels of TGF- signals. (right) 
Deletion of Msi2 in HSCs leads to loss of qui-
escence and increased symmetric commit-
ment toward differentiated progeny. 
Additionally, Msi2 loss leads to a reduction in 
My-HSCs, which are unresponsive to TGF-–
induced proliferative signals.JEM Vol. 211, No. 1 
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(Charlesworth et al., 2006; Arumugam et al., 2010, 2012). This 
can explain why Msi2 can bind to both TGFBR1 and Smad3 
and yet affect their translation differently. It will be interesting 
to understand how Msi2 can act either as a translation inhibi-
tor or activator.
Our study characterizes Msi2 deletion in the hematopoietic 
system and uses global RNA binding analysis to identify a novel 
link between Msi2 and TGF- signaling in regulating quies-
cence and myeloid/lymphoid lineage determination of HSCs. It 
will be interesting to test whether this pathway is retained and 
functionally important for leukemic stem cells or whether Msi2 
modulates other critical pathways in these cells. Collectively, 
these results have important implications for understanding how 
the activity of RNA-binding proteins contribute to normal tis-
sue homeostasis and stem cell function and how MSI2 and its 
targets contribute to oncogenic transformation.
MATERIALS AND METHODS
qRT-PCR. mRNA was isolated from FACS-purified populations using 
TRIzol (Life Technologies) and the RNeasy RNA extraction kit (QIA-
GEN) and reverse transcribed into cDNA with iSCRIPT (Bio-Rad Labora-
tories). qRT-PCR was performed as previously described with the indicated 
primers (supplemental dataset) for p21, p27, p57, Actin, JunB, Gfi1, Id2, 
Gata2, Evi1, c-myc, and Egr1. qRT-PCR primers designed for 3 UTRs for 
RIP samples are listed in the supplemental dataset.
Msi2 conditional knockout mice. We cloned one loxP site 3 of the tran-
scriptional start site and a floxed PGK-neomycin-resistance cassette 3 of the 
fifth intron using a Kpn1 fragment encompassing the 3 region of the Msi2 
locus cloned into the pBS backbone. (Fig. 1 a). The targeting vector was elec-
troporated into V6.5 embryonic stem cells, and G418-resistant colonies were 
subcloned. Homologous recombinants were detected by Southern blotting 
using 5 and 3 external probes, and correctly targeted embryonic stem clones 
were transiently treated with Cre to remove the Neo resistance cassette (veri-
fied by Southern blotting), before blastocyst injection of conditional 2-lox 
clones. Resulting chimeras were backcrossed to C57BL/6 mice and the F1 
generation was bred to Mx1 Cre mice on a C57BL/6 background. Deletion 
was initiated using pIpC (GE Healthcare) by intraperitoneal injections every 
3–4 d as indicated (150 mg/kg) per mouse three times. Cre recombination of 
the conditional 2-lox (floxed) locus to the inactive, 1-lox (null) locus was veri-
fied by Southern blotting after cutting genomic DNA with XbaI and hybrid-
ization with a 5 external probe. All of the animal experiments were approved 
under the Institutional Animal Care and Use Committee.
Noncompetitive transplants. Noncompetitive transplants were performed 
with 106 BM cells from 6–10-wk-old Msi2flox/flox or littermate control mice, 
transplanted into lethally irradiated B6SJL congenic CD45.1 recipients. In 
the primary transplants with Msi2/ BM, transplants were performed 12–16 
wk after Msi2 deletion. In the cell-autonomous transplants, transplanted mar-
row was allowed to engraft for 4–6 wk before pIpC was administered. Pe-
ripheral blood chimerism was assessed after engraftment before deletion to 
verify successful engraftment.
Peripheral blood analysis. Peripheral blood was collected from the retro-
orbital cavity using a heparinized glass capillary tube. Complete peripheral 
blood count analysis including a differential blood count was obtained by 
using Hemavet (Drew Scientific).
Flow cytometry. BM cells or splenocytes were harvested and subjected to 
red blood cell lysis. Fresh or frozen cells were stained with the following Abs: 
CD45.2-FITC and CD45.1-APC, Mac1-PE, Gr1-APC, c-Kit–APC, CD71-
PE, Ter119-APC, B220-PE, and CD3-APC (BD) and analyzed on the BD 
previously published studies connecting Musashi to Numb 
and to Notch signaling (Imai et al., 2001; Ito et al., 2010; Kharas 
et al., 2010), we were unable to uncover a role for these path-
ways in HSPCs. A study of normal CD34+ cells from healthy 
BM displayed no correlation between MSI2 and NUMB ex-
pression, whereas the same study found reduced expression   
of NUMB in MDS/AML samples with the highest level of 
MSI2 expression (Pereira et al., 2012). Finally, we are unable 
to detect binding of NUMB in our HITS-CLIP analysis or 
increased expression after MSI2-shRNA depletion in K562 
cells (unpublished data).
To gain an unbiased understanding of the pathways down-
stream of Msi2 in maintaining proper HSC function, we used 
transcriptome-wide  MSI2  RNA–binding  target  analysis.   
A previous global study examining Msi1 using native RIP 
(RIP-CHIP) identified targets known to contribute to onco-
genic transformation (de Sousa Abreu et al., 2009). In our 
study, we used a recently developed approach for studying 
RNA-binding proteins (HITS-CLIP) that involves UV cross-
linking to generate more specificity in binding targets through 
direct interactions between target proteins and RNA (Chi   
et al., 2009). This allowed us to define a global map of MSI2 
direct binding RNA targets for the first time. Moreover, in-
tegration of our HITS-CLIP and transcriptome analysis 
performed in Msi2-deficient HSPCs identified a developmen-
tal program that is controlled through many direct RNA– 
protein interactions.
Based on the phenotypes we observed in self-renewal, 
quiescence, and our genomic data, we focused on the TGF- 
pathway. A previous study in vitro with TGF ligands suggested 
that TGF- signaling could block proliferation of HSCs and 
maintain quiescence (Sitnicka et al., 1996). However, TGF-1 
signaling–deficient mice revealed no detectable alterations in 
the HSC compartment in vivo, but demonstrated increased 
proliferation in vitro after SCF stimulation (Larsson et al., 
2003, 2005). Additionally, the loss of Tgfbr1 had normal HSC 
function  and  self-renewal  potential  (Larsson  et  al.,  2003, 
2005). In contrast, loss of Tgfbr2 or Smad4 resulted in reduced 
chimerism in competitive transplants (Karlsson et al., 2007; 
Yamazaki et al., 2011). Other studies have demonstrated that 
My-HSCs and myeloid cell lines treated with low levels of 
TGF-1 in vitro exhibit increased proliferation (Kale and 
Vaidya,  2004;  Kale,  2004;  Karlsson  et  al.,  2007;  Chambers   
et al., 2008; Challen et al., 2010).
Although we observed an increase in TGFBR1, this did 
not translate into increased signaling, as we found a reduction 
in SMAD2/3 phosphorylation, total levels of SMAD3, de-
creased p57 expression, and insensitivity to the growth stimu-
latory effects of TGF-. Furthermore, the reduced TGF- 
signaling ultimately resulted in a decrease in HSC self-renewal 
and a dramatic reduction in My-HSCs. This observation pro-
vides a potential explanation for the reduction in the myeloid 
lineage compared with the lymphoid lineage.
Msi2 is well known for its function as a translation inhibi-
tor, but previous studies have shown that Msi2 can also act   
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proliferation, 50 HSCs were sorted into a well of a 96-well plate containing 
media as above with different doses of TGF-b1 (R&D Systems). Cells were then 
counted 7 d later using counting beads (Life Technologies) with flow cytometry.
Statistical analyses. For bar graphs, the unpaired two-tailed Student’s t test was 
used to compute p-values, except where stated otherwise. Error bars reflect the 
SEM, except where stated otherwise. All statistical analyses were performed 
using Prism 4.0 (GraphPad Software) and the R statistical environment.
RIP. 20 million K562 control vector cells and cells overexpressing Flag-MSI2 
were used for RIP using the Magna RIP RNA binding protein immuno-
precipitation kit (EMD Millipore). In brief, cells were washed with cold PBS 
and lysed with RIP lysis buffer provided from the kit. 5 µg anti–Flag M2 Ab 
(Sigma-Aldrich), anti–rabbit Ab, or anti-Msi2 Ab (EMD Millipore), which 
were incubated with magnetic beads, were used to immunoprecipitate Flag–
MSI2–RNA complexes. Immunoprecipitated complexes were washed and 
treated with proteinase K. RNA was extracted using the phenol/chloroform 
method, and the resulting RNA was converted to cDNA using the Verso 
cDNA kit (Thermo Fisher Scientific). cDNA was then used for qRT-PCR 
validating candidates from the HITS-CLIP.
UV cross-linking, immunoprecipitation, and high-throughput RNA 
sequencing (HITS-CLIP). The protocol used is mainly based on UV cross-
linking and immunoprecipitation with high-throughput RNA sequencing 
(HITS-CLIP) published by Chi et al. (2009). In brief, 100 million empty 
vector control– or Flag-MSI2–overexpressing K562 cells were UV cross-
linked with 4,000 J at 265 nm on ice. Cells were washed three times with 
cold PBS containing protease inhibitors, and the cell pellets were resuspended 
in a low salt buffer that is optimized for reducing nonspecific RNA interac-
tions (100 mM NaCl, 0.1% SDS, 0.5% sodium deoxycholate, 0.5% Nonidet 
P-40) with protease inhibitors. Cells were sonicated with a Branson probe 
sonicator for three cycles of 10 s (0.7 s on/1.3 s off) at 20% power on ice. The 
lysates were then rested on ice for 20 min. RQ1 DNase (Promega) was added 
to the lysates and incubated at 37°C for 5 min. RNase A (USB Products)   
was added at a concentration of 1:1,000 and incubated at 37°C for 10 min.   
Lysates were spun and supernatants were incubated with protein G Dyna-
beads (Invitrogen) that were preincubated with anti–Flag M2 Ab in low salt 
buffer (Sigma-Aldrich). Beads were washed with low salt wash buffer three 
times followed by two washes with high salt buffer (500 mM NaCl, 0.1% 
SDS, 0.5% sodium deoxycholate, 0.5% Nonidet P-40) to reduce nonspecific 
protein interactions. 5 µg proteinase K (Invitrogen) was added to the washed 
beads and incubated at 70°C for 2 h. RNA was extracted using standard 
phenol/chloroform extraction methods, the RNA was precipitated at 80°C 
overnight, and the resulting RNA pellets were washed with 80% ethanol to 
retain short RNA fragments. RNA sizes were assessed on a 2100 Bioanalyzer 
(pico chip), and the sizes of extracted RNA ranged between 40 and 200 bases 
in length. RNA libraries were prepared and barcoded at the Broad Institute 
Sequencing Core facility and then sent to the core facility at the Sloan-
Kettering Institute for single-end Illumina sequencing. A first round of se-
quencing for one control and two replicates produced 20 million 36-bp 
alignable reads for each library. The second replicate was sequenced for an 
additional 60 million reads to enhance coverage.
Statistical analysis and plots of HITS-CLIP data. To identify potential 
binding sites, we used a custom R package to call peaks in read coverage in 
the Msi2 HITS-CLIP experiments (Loeb et al., 2012), and we tested for dif-
ferential binding between Msi2-overexpressing cells and control while cor-
recting for differential expression using a joint generalized linear model of 
HITS-CLIP and RNA sequencing read counts in the candidate peak re-
gions. Peak windows that were differentially bound at an FDR threshold of 
0.1 were reported unless otherwise noted.
Processing  CLIP  reads. Using the FASTX-Toolkit from the Hannon 
Laboratory (Cold Spring Harbor Laboratory, Cold Spring Harbor, NY),   
3 ends of reads were trimmed until the base quality score was not <30 and   
FACSCalibur instrument. Staining for multiparameter flow cytometry was 
performed after a c-kit enrichment using 10 µl MACS beads (CD117) per 
mouse and then run on an AutoMACS (Miltenyi Biotec) according to the 
manufacturer’s instructions. The cells were then stained with the following 
cocktail: (Lineage; CD3, CD4, CD8, Gr1, B220, CD19, and TER119 all con-
jugated with PeCy5), Sca-Pac Blue, CD34-FITC or CD45.2-FITC, SLAM-
APC, CD48-PE, c-KIT–Alexa Fluor 780, and FcgRIIb-PeCy7 (Fig. 2 d); HPCs 
(Linloc-Kit+Sca1), GMPs (LK, FcRIIbhiCD34+), CMPs (LK, FcRIIbmid 
CD34+), MEPs (LK, FcRIIbloCD34), B cells (B220+), and T cells (CD3+) 
from the spleen were also sorted. For analysis of LMPPs and CLPs, the fol-
lowing cocktail was used: Lineage marker mix–PeCy5, Sca-Pecy7 IL-7Ra–Pac 
Blue, Flk2-PE, CD34-FITC, and Kit-APC (Martin et al., 2003; Adolfsson et al., 
2005; Karsunky et al., 2008).
Colony-forming assays. 200 sorted HSCs or 500 sorted HSPCs were 
plated in in M3434 methylcellulose media (STEMCELL Technologies), and 
colonies were scored after 10 d and 7 d, respectively.
Microarray  analysis  of  Msi2  expression  in  conditional  knockout 
mice. HSPCs (LineageloScaI+c-Kit+) were sorted 4 wk after pIpC injection. 
RNA was extracted using TRIzol and the RNeasy RNA extraction kit. 
RNA was then amplified using the NUGEN Pico amplification kit, frag-
mented, and hybridized on Mouse Expression Array 430 2.0 (Affymetrix) at 
the Microarray Core Sub-Facility (Molecular Genetics Core, Division of 
Genetics, Intellectual and Developmental Disabilities Research Center, Chil-
dren’s Hospital Boston; CLS 16). Signal normalization was performed by 
robust multi-array average (RMA) method. Data were analyzed using GSEA 
across the complete list of genes ranked by signal to noise ratio (microarray 
data, n = 4 Msi2flox/flox mice and n = 4 Msi2/ mice). The microarray data 
can be found in the GEO database under accession no. GSE53385.
Immunofluorescence. HSCs or HSPCs were sorted from primary mice   
6 wk after pIpC and cultured with STIF media (Stemspan media [STEMCELL 
Technologies] containing 10 ng/ml heparin, 10 ng/ml SCF, 20 ng/ml TPO, 
20 ng/ml IGFII, and 10 ng/ml FGF) in 96 round-bottom wells for 16 h and 
then treated with 10 nM Nocodazole for 24 h. Cells that were fixed with 
1.5% paraformaldehyde and permeabilized with cold methanol were cyto-
spun onto glass slides and were then stained on slides with anti-Numb 
(Abcam) and secondary Ab (donkey anti–goat Alexa flour 546; Molecular 
Probes) with DAPI counterstaining (Kharas et al., 2010). Symmetric versus 
asymmetric percentages were assessed based on quantification of the signal 
intensity of each cell (divided by surface area) normalized for background 
staining using an Axio Imager M2 microscope (Carl Zeiss), followed by a 
confirmatory visual inspection that determined symmetric commitment ver-
sus symmetric renewal. Daughter cells with elevated equivalent staining of 
Numb were counted as symmetric commitment, whereas if one daughter 
cell contained more staining than the other cell, then the division was con-
sidered an asymmetric division. If there was low or no staining in the daugh-
ter pairs, this was scored as a symmetric renewal division. Cells were also 
stained for phospho-Smad2/3 (EMD Millipore), and staining was quantified 
as above in all cells including nondividing cells. Phospho-Smad2/3 was   
also performed on HSCs directly isolated from animals with similar results. 
Freshly isolated HSCs that were fixed and permeabilized as mentioned above 
were stained on glass slides for c-Myc (Epitomics), TGFBR1 (Abcam), and 
pan-Smad3 (Cell Signaling Technology) using secondary Ab (donkey anti–
rabbit Alexa Fluor 488; Molecular Probes). Quantification of the signal in-
tensity of each cell (divided by surface area) normalized for background 
staining was measured using AxioVision software (Carl Zeiss).
In vitro HSC and HSPC proliferation assay. We sorted 100 HSCs (LSK 
CD48CD150+) and 1,000 HSPCs (LSK+CD150 and LSK+CD150+CD48+) 
into Stemspan media containing 10 ng/ml IL-3, 10 ng/ml IL-6, 50 ng/ml SCF, 
10 ng/ml TPO, and 20 ng/ml Flt3L in a round-bottom plate and counted at 
days 7 and 5, respectively. Then cells were analyzed using counting beads and 
indicated markers for differentiation by flow cytometry. For TGF-stimulated JEM Vol. 211, No. 1 
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abundance or by differential Msi2 binding. To identify real differential bind-
ing events, it is necessary to integrate gene expression data into the analysis.
Specifically, we jointly modeled read count data from HITS-CLIP and 
RNA-Seq with a novel generalized linear model approach. We represented 
the read count from a window containing peak i in sample j as Kij, which was 
seen as realization of random variable Kij; here, the read count represents 
either HITS-CLIP reads or RNA-Seq reads in the window, depending on 
sample j. It is assumed that Kij follows a negative binomial distribution, 
which has been widely used in modeling read count data (Anders et al., 
2012; McCarthy et al., 2012).
For each peak i, the expected value of Kij, denoted by ij, is fit via a 
logarithmic link by the following model:
	 log log
: : µ β β β β ij i i
CLIP
j
CLIP
i
OE
j
OE
i
CLIP OE
j
CLIP OE
j X X X N = + + + +
0  . .	
Here  N j   represented scaled library size of sample j, which was the total 
read count in sample j scaled by the weighted trimmed mean of log expres-
sion ratios (Robinson and Oshlack, 2010). It was included as a normaliza-
tion factor. After normalization, the logarithm of this variable is decomposed 
into four factors, where the regression coefficients have the following in-
terpretation:  βi
0  represents the baseline log expression level measured by 
the window at peak i; βi
CLIP  represents the baseline log read count ratio of 
CLIP reads to RNA-Seq reads at peak i; βi
OE  represents the effect of Msi2 
overexpression  on  read  counts  caused  by  mRNA  expression  changes.   
Finally, the interaction term  βi
CLIP OE :  represents differential Msi2 binding 
caused by overexpression; this coefficient will be nonzero if there is differ-
ential binding even after controlling for differential mRNA expression. 
Factors X j
CLIP,  X j
OE,  and X j
CLIP OE :  equal 1 or 0, depending on the condi-
tion and library type of sample j. To test whether the interaction term is 0, 
we fit data to both the full model and a reduced model without the inter-
action term. Then the deviances of two models were used to conduct a 
likelihood ratio test. If there is no true differential binding effect, the dif-
ference in deviances between the nested models should be small compared 
with a 2 distribution with one degree of freedom. In this way, we were 
able to characterize the significance of differential binding with a p-value. 
Finally, we defined Msi2-binding sites as sites with Benjamini-Hochberg–
adjusted p-value <0.1 and βi
CLIP OE :  > 0. The above analysis was conducted 
using the edgeR package (McCarthy et al., 2012).
Visualization of GSEA results. GSEA (Subramanian et al., 2005) was 
conducted independently on expression profiles of Msi2/ LSKs and HITS-
CLIP targets in K562. The overlapping gene sets were significantly enriched 
(FDR < 0.01) in both analyses. The relationships between those common 
gene sets were visualized using HTSanalyzeR (Wang et al., 2011) and igraph 
packages in R. In Fig. 7 (f and g), each node represents a gene set, and its size 
represents the number of genes in the gene set. An edge between two nodes 
indicates that two gene sets share part of the genes, and the width of each 
edge shows the percentage of overlap between two gene sets.
Online supplemental material. Fig. S1 shows the gating strategy for Fig. 1 g. 
Fig. S2 shows the gating strategy for Fig. 2. Fig. S3 shows the gating strat-
egy for Fig. 3. Fig. S4 shows the gating strategy for Fig. 4. Fig. S5 shows the 
gating strategy for Fig. 5 (a and e). Table S1, included as a separate Excel file, 
shows microarray analysis of the differentially expressed genes in Msi2-
deficient LSK cells. Table S2, included as a separate Excel file, lists the ad-
ditional curated gene sets utilized in GSEA analyses. Table S3, included as   
a separate Excel file, lists the statistically significant gene sets from Msi2-
deficient LSK microarray expression analysis. Table S4, included as a sepa-
rate Excel file, shows the location and number of the significant HITS-CLIP 
targets. Table S5, included as a separate Excel file, lists the statistically sig-
nificant gene sets from the HITS-CLIP ranked list in K562 cells. Table S6, 
included as a separate Excel file, lists the significant and overlapping gene 
sets from the HITS-CLIP and microarray analyses. The supplemental data-
set, included as a separate Excel file, shows primer sequences used for the   
retained if the remaining read length was at least 20 nt. After trimming, we 
mapped CLIP reads to the hg19 human genome with Bowtie2 (Langmead 
and Salzberg, 2012).
Identification  and  annotation  of  Msi2-binding  sites  from  HITS-
CLIP data. To identify possible Msi2-binding sites in HITS-CLIP data, we 
reimplemented our previous CLIP-seq peak-calling pipeline as an R package 
to enable efficient and transcriptome-wide identification and annotation of 
peaks mapped by various sequencing technologies (Loeb et al., 2012). In 
brief, our approach was inspired by edge detection in computer vision, where 
sharp changes in brightness in an image are detected as edges of an object by 
computing the rate of change of the intensity gradient.
To identify peaks, we first combined the reads from all of the HITS-
CLIP experiments together. Reads previously trimmed for low base quality 
were extended to a minimum length of 30 nt. We then constructed a 1D sig-
nal profile of read coverage, K[x], which contains cumulative read counts for 
each position x from all HITS-CLIP libraries. To simultaneously smooth and 
identify edges in the signal, this profile was convolved with a kernel derived 
from the second derivative of a Gaussian (gD), with a mean of 0, standard de-
viation of 1, and bandwidth set to 15 nt. The edges in the original signal are 
located at the zero-crossings of the convolved signal.
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The zero-crossings of the second derivative that switch from positive to neg-
ative indicate the edges that start a peak, and the points that switch from neg-
ative  to  positive  identify  the  ends  of  each  peak.  Once  the  peaks  were 
identified, we then quantified peaks in each experiment by counting the 
number of reads from each experiment that overlapped with each peak. 
Reads that overlapped more than one peak were assigned to the peak with 
which it had maximal overlap.
After peak identification, each CLIP peak was annotated according to 
the RefSeq gene annotation for hg19 (downloaded from UCSC on April 4, 
2012). Genes with multiple isoforms were reduced to a unified gene model, 
which is the union of all annotated exons. To compensate for possible errors 
in annotation, for each gene we extended the first exon 1 kb upstream and 
the last exon 5 kb downstream. Using these models, HITS-CLIP peaks were 
then annotated with the specific genomic region (CDS, intron, 5 UTR, and   
3 UTR) that the peaks overlap. If a genomic region was assigned to multiple 
categories, we assigned it to one of them with the following order: 3 UTR, 
CDS, 5 UTR, and intron. Peaks that mapped to multiple genomic regions 
were assigned to the region with maximum overlap.
Processing RNA-Seq reads. Paired-end RNA-Seq reads were aligned to 
human genome hg19 with Tophat (Trapnell et al., 2010). Then we counted 
the number of RNA-Seq reads within each previously defined HITS-CLIP 
binding site using the HTSeq package from the Huber Laboratory (Euro-
pean Molecular Biology Laboratory, Heidelberg, Germany).
Identification of significant HITS-CLIP peaks by integrating gene 
expression. As flag-tagged Msi2 protein was not expressed in control cells, 
HITS-CLIP reads from the control sample were generated by nonspecific 
binding of the Ab and other sources of background noise. A fraction of reads 
in samples with overexpressed Msi2 also came from these noise sources (Chi 
et al., 2009). Therefore, we were interested in identifying HITS-CLIP peaks 
with significantly higher read counts in Msi2-overexpressing cells relative   
to control, as they are likely to be the real Msi2-binding sites. However,   
as mRNA expression levels may change between different conditions, dif-
ferential read counts at a site can be caused either by a change in transcript 86 Musashi-2 balances HSC homeostasis | Park et al.
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